Tate & Lyle to partner with Solvay on digestive health ingredient
Solactis® Galactofructose to deliver wide ranging health benefits to the food beverage market
Tate Lyle has today announced that it has signed an agreement with Solvay to sell the ingredient Solactis® Galactofructose in bakery and other food and beverage applications in Europe (excluding Spain and Portugal), the Middle East and Africa.
Solactis® Galactofructose is a non-digestible carbohydrate derived from milk. Following comprehensive clinical trials, Galactofructose has been shown to deliver wide ranging health benefits as a prebiotic ingredient which also regulates digestive transit at very low dosages. In addition scientific results suggest that it could be beneficial in stimulating mineral absorption, and helpful in managing weight.
Galactofructose was first employed as a food ingredient for infant milk formulas in the 1950’s and since the 1960’s has also been used in the pharmaceutical industry in North America, Asia and Europe. It is supported by more than 50 years of scientific research, 30 of them conducted by Solvay. The ingredient also holds a long history of use in Asia where it has been employed in dairy applications and in infant nutrition.
Tate Lyle and Solvay will use Solactis® Galactofructose to create a range of “better for you” food applications for and with customers. They will leverage synergies within Tate Lyle’s existing food ingredients portfolio, including products such as Sta-lite® Polydextrose and Promitor™ Resistant Starch.
Tate Lyle will be showcasing Solactis® Galactofructose as a part of its Enrich™ offering at Food Ingredients Europe 09. At stand Number 8M35 visitors will be able to taste a first series of innovative prototypes such as juice drinks and bakery items.
Commenting, James Blunt, Vice-President Sales Marketing Tate Lyle Food Ingredients Europe said: “Galactofructose is an extremely functional food ingredient and has been shown to have excellent digestive effects, as well as other important benefits.
“Our partnership with Solvay is a natural fit. We will be able to combine their substantial experience and nutritional knowledge of Galactofructose with our own ingredients expertise, to develop products which are healthy and taste great.”
“Galactofructose complements our health and wellness strategy very well, so we’re delighted to be able to bring it to our customers now.”
Pascal Ronfard, Solactis® Program Manager of Solvay said: “This dairy derivative has proved to be a mild but efficient digestion facilitator and we believe it has great potential in the food world.
“The partnership with Tate Lyle will allow us to combine their excellent insight into consumer habits and preferences, top quality applications expertise and far reaching distribution network, with our knowledge of the nutritional and functional benefits of Galactofructose. Together we will develop more healthy food products for European consumers. We’re looking forward to a very fruitful partnership.”
Ends
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2012, Tate Lyle sales totalled £3.1 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
